Jeff Liter
Company: Luminary Therapeutics
Job title: President & Chief Executive Officer
Seminars:
The Role of gdT Cell Therapies in Autoimmunity 1:45 pm
An alternative to CD19 targeting Identifying and removing autoreactive B cells by directlytargeting the B cell activating factor receptors Eliminating the cause of inflammation at the sourceRead more
day: Conference Day Two - Track A - PM
Fireside Chat: Next Generation GDT Cell Therapy for Autoimmune Disorders 2:45 pm
Exploration of preclinical and clinical evidence supporting the use of gamma delta cell therapies in autoimmune conditions. Addressing safety considerations and potential adverse effects associated with gamma delta cell treatments. Evaluation of the challenges and opportunities in translating gamma delta cell therapies from bench to bedside for autoimmune diseases. Consideration of patient selection criteria and…Read more
day: Conference Day Two - Track A - PM
Clinical Development & Product Optimization 10:50 am
day: Conference Day One - Track B